{"id":348707,"date":"2026-11-16T14:31:02","date_gmt":"2026-11-16T09:01:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=348707"},"modified":"2026-11-16T14:31:02","modified_gmt":"2026-11-16T09:01:02","slug":"twenty-six-percent-quarterly-profit-growth-stocks-to-buy","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/","title":{"rendered":"26 Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Dr Lal Rs 1,993. L&#038;T Rs 4,144. Marico Rs 900.00. Sun Pharma Rs 1,880. Trent Rs 3,165. NSE closing prices, 13 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Five 26 percent quarterly profit growth stocks to buy on the November 2026 watchlist are Dr Lal PathLabs, Larsen and Toubro, Marico, Sun Pharmaceutical Industries and Trent. All five grew revenue in their latest full year, and all five also grew net profit. Larsen and Toubro has the lowest P\/E at 25.06, while Marico leads on return on equity at 41.85%. Check each valuation against your own risk appetite before acting.<\/p>\n<\/p><\/div>\n<p>The 26 percent quarterly profit growth stocks to buy in November 2026 start with five listed names: Dr Lal PathLabs, Larsen and Toubro, Marico, Sun Pharmaceutical Industries and Trent. These five companies each grew net profit by about 25% to 27% in the latest reported quarter compared with a year earlier. Larsen and Toubro, Sun Pharmaceutical Industries and Trent are part of the <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> index, Marico is part of the <a href=\"https:\/\/univest.in\/indices\/nifty-fmcg\/nifty-fmcg-share-price-today\">Nifty FMCG<\/a> index and Sun Pharmaceutical Industries is part of the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index.<\/p>\n<p>This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 26 percent quarterly profit growth stocks to buy to a portfolio. All prices are NSE closing prices of 13 November 2026, and financials come from company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=twenty-six-percent-quarterly-profit-growth-stocks-to-buy\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Which_Are_the_Best_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy_in_November_2026\" title=\"Which Are the Best 26 Percent Quarterly Profit Growth Stocks to Buy in November 2026?\">Which Are the Best 26 Percent Quarterly Profit Growth Stocks to Buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Why_These_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy_Are_in_Focus\" title=\"Why These 26 Percent Quarterly Profit Growth Stocks to Buy Are in Focus\">Why These 26 Percent Quarterly Profit Growth Stocks to Buy Are in Focus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Dr_Lal_PathLabs_The_Diagnostics_Leader_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Dr Lal PathLabs: The Diagnostics Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy\">Dr Lal PathLabs: The Diagnostics Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Larsen_and_Toubro_The_Infrastructure_Conglomerate_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Larsen and Toubro: The Infrastructure Conglomerate Among 26 Percent Quarterly Profit Growth Stocks to Buy\">Larsen and Toubro: The Infrastructure Conglomerate Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Marico_The_Coconut_Oil_and_Edible_Oil_Brand_Owner_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Marico: The Coconut Oil and Edible Oil Brand Owner Among 26 Percent Quarterly Profit Growth Stocks to Buy\">Marico: The Coconut Oil and Edible Oil Brand Owner Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Sun_Pharmaceutical_Industries_The_Pharma_Heavyweight_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Sun Pharmaceutical Industries: The Pharma Heavyweight Among 26 Percent Quarterly Profit Growth Stocks to Buy\">Sun Pharmaceutical Industries: The Pharma Heavyweight Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Trent_The_Fashion_Retail_Leader_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Trent: The Fashion Retail Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy\">Trent: The Fashion Retail Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\" title=\"Growth Snapshot: Latest Full Year and Latest Quarter\">Growth Snapshot: Latest Full Year and Latest Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Factors_That_Move_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Factors That Move 26 Percent Quarterly Profit Growth Stocks to Buy\">Factors That Move 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Risks_to_Keep_in_Mind_Before_Buying_26_Percent_Quarterly_Profit_Growth_Stocks\" title=\"Risks to Keep in Mind Before Buying 26 Percent Quarterly Profit Growth Stocks\">Risks to Keep in Mind Before Buying 26 Percent Quarterly Profit Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#How_to_Choose_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"How to Choose 26 Percent Quarterly Profit Growth Stocks to Buy\">How to Choose 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#How_to_Invest_in_26_Percent_Quarterly_Profit_Growth_Stocks\" title=\"How to Invest in 26 Percent Quarterly Profit Growth Stocks\">How to Invest in 26 Percent Quarterly Profit Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Frequently_Asked_Questions_on_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\" title=\"Frequently Asked Questions on 26 Percent Quarterly Profit Growth Stocks to Buy\">Frequently Asked Questions on 26 Percent Quarterly Profit Growth Stocks to Buy<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Which_are_the_best_26_percent_quarterly_profit_growth_stocks_to_buy_in_November_2026\" title=\"Which are the best 26 percent quarterly profit growth stocks to buy in November 2026?\">Which are the best 26 percent quarterly profit growth stocks to buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Is_Larsen_and_Toubro_a_good_stock_to_buy_from_this_26_Percent_Quarterly_Profit_Growth_list\" title=\"Is Larsen and Toubro a good stock to buy from this 26 Percent Quarterly Profit Growth list?\">Is Larsen and Toubro a good stock to buy from this 26 Percent Quarterly Profit Growth list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Are_these_26_percent_quarterly_profit_growth_stocks_expensive_right_now\" title=\"Are these 26 percent quarterly profit growth stocks expensive right now?\">Are these 26 percent quarterly profit growth stocks expensive right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Which_of_these_26_percent_quarterly_profit_growth_stocks_pay_a_dividend\" title=\"Which of these 26 percent quarterly profit growth stocks pay a dividend?\">Which of these 26 percent quarterly profit growth stocks pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#Which_stock_on_this_list_has_the_highest_return_on_equity\" title=\"Which stock on this list has the highest return on equity?\">Which stock on this list has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#What_are_the_risks_of_investing_in_26_percent_quarterly_profit_growth_stocks\" title=\"What are the risks of investing in 26 percent quarterly profit growth stocks?\">What are the risks of investing in 26 percent quarterly profit growth stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/twenty-six-percent-quarterly-profit-growth-stocks-to-buy\/#How_can_I_invest_in_26_percent_quarterly_profit_growth_stocks_in_India\" title=\"How can I invest in 26 percent quarterly profit growth stocks in India?\">How can I invest in 26 percent quarterly profit growth stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Which_Are_the_Best_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy_in_November_2026\"><\/span><strong>Which Are the Best 26 Percent Quarterly Profit Growth Stocks to Buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The best 26 percent quarterly profit growth stocks to buy in November 2026 for a watchlist are Dr Lal PathLabs, Larsen and Toubro, Marico, Sun Pharmaceutical Industries and Trent. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Market Cap<\/th>\n<th>P\/E<\/th>\n<th>ROE<\/th>\n<th>Dividend Yield<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Dr Lal PathLabs<\/td>\n<td>1,993<\/td>\n<td>Rs 32,115 crore<\/td>\n<td>58.78<\/td>\n<td>20.13%<\/td>\n<td>1.07%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lt\/larsen-and-toubro-ltd-share-price-today\">Larsen and Toubro<\/a><\/td>\n<td>4,144<\/td>\n<td>Rs 5,23,536 crore<\/td>\n<td>25.06<\/td>\n<td>15.81%<\/td>\n<td>1.00%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/marico\/marico-ltd-share-price-today\">Marico<\/a><\/td>\n<td>900.00<\/td>\n<td>Rs 1,00,434 crore<\/td>\n<td>51.46<\/td>\n<td>41.85%<\/td>\n<td>0.52%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td>1,880<\/td>\n<td>Rs 4,22,991 crore<\/td>\n<td>34.91<\/td>\n<td>13.74%<\/td>\n<td>0.91%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/trent\/trent-ltd-share-price-today\">Trent<\/a><\/td>\n<td>3,165<\/td>\n<td>Rs 1,52,824 crore<\/td>\n<td>84.22<\/td>\n<td>24.62%<\/td>\n<td>0.09%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On valuation, Dr Lal PathLabs and Sun Pharmaceutical Industries sit close to it; Larsen and Toubro, Marico and Trent carry a premium. Valuation is the first filter for any 26 percent quarterly profit growth stocks to buy list, and it is covered again in the risk section.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy_Are_in_Focus\"><\/span><strong>Why These 26 Percent Quarterly Profit Growth Stocks to Buy Are in Focus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the latest reported quarter was higher than a year earlier for all five. The list covers a diagnostics chain, the country&#8217;s largest engineering and construction company, the maker of Parachute and Saffola, the largest pharma company by sales and the owner of the Westside and Zudio stores. Investors comparing the best stocks with 26 percent quarterly profit growth in India usually check whether growth is steady, how the shares are valued and how much debt the company carries.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_The_Diagnostics_Leader_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Dr Lal PathLabs: The Diagnostics Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is one of India&#8217;s largest diagnostic chains, with a national network of labs and collection centres. The stock trades at Rs 1,993 with a market capitalisation of Rs 32,115 crore and a P\/E of 58.78, against an industry P\/E of 61.50.<\/p>\n<p>FY26 revenue rose 12.1% to Rs 2,864 crore and net profit rose 3.6% to Rs 510 crore. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit grew 27.2% to Rs 170 crore.<\/p>\n<p>Return on equity is 20.13%, debt-to-equity is 0.08, and the dividend yield is 1.07%. Promoters hold 52.93%, foreign institutions 18.73% and domestic institutions 21.58% as of September 2026. Domestic institutional holding has risen from 18.49% to 21.58% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Larsen_and_Toubro_The_Infrastructure_Conglomerate_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Larsen and Toubro: The Infrastructure Conglomerate Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Larsen and Toubro is an engineering and construction conglomerate spanning infrastructure, defence, energy and IT services. At Rs 4,144, the stock has a market capitalisation of Rs 5,23,536 crore and trades at 25.06 times earnings, while the industry P\/E is 21.53.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 2,91,635 crore, up 12.2% year on year, with net profit at Rs 19,159 crore, up 8.3%. The September 2026 quarter added revenue of Rs 81,056 crore (up 16.8%) and net profit of Rs 5,915 crore (up 26.2%).<\/p>\n<p>Return on equity is 15.81%, debt-to-equity is 1.24, and the dividend yield is 1.00%. The company has no identified promoter, with foreign institutions holding 19.21% and domestic institutions 42.86% as of September 2026. A point to keep in view: debt is higher than most names on this list.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check 26 Percent Quarterly Profit Growth Stocks Live on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Marico_The_Coconut_Oil_and_Edible_Oil_Brand_Owner_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Marico: The Coconut Oil and Edible Oil Brand Owner Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Marico is the maker of Parachute coconut oil, Saffola and Set Wet. Its market capitalisation is Rs 1,00,434 crore, the share price is Rs 900.00 and the P\/E of 51.46 compares with an industry P\/E of 33.02.<\/p>\n<p>Over FY26, net profit rose 9.3% to Rs 1,813 crore on revenue of Rs 13,815 crore, which was up 25.1%. The latest quarter, the June 2026 quarter, brought revenue of Rs 4,005 crore, up 22.2% year on year, and net profit of Rs 652 crore, up 27.1%.<\/p>\n<p>Return on equity is 41.85%, debt-to-equity is 0.13, and the dividend yield is 0.52%. Promoters hold 58.83%, foreign institutions 22.26% and domestic institutions 13.73% as of September 2026. Domestic institutional holding has risen from 11.99% to 13.73% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharmaceutical_Industries_The_Pharma_Heavyweight_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Sun Pharmaceutical Industries: The Pharma Heavyweight Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is India&#8217;s largest pharmaceutical company by market value, with a strong domestic franchise and a growing specialty portfolio in the US. The stock trades at Rs 1,880 with a market capitalisation of Rs 4,22,991 crore and a P\/E of 34.91, against an industry P\/E of 37.65.<\/p>\n<p>FY26 revenue rose 12.7% to Rs 61,674 crore and net profit rose 5.3% to Rs 11,565 crore. In the June 2026 quarter, revenue grew 11.9% year on year to Rs 16,024 crore, while net profit grew 26.4% to Rs 2,911 crore.<\/p>\n<p>Return on equity is 13.74%, debt-to-equity is 0.06, and the dividend yield is 0.91%. Promoters hold 52.68%, foreign institutions 14.36% and domestic institutions 22.27% as of September 2026. Domestic institutional holding has risen from 20.23% to 22.27% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Trent_The_Fashion_Retail_Leader_Among_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Trent: The Fashion Retail Leader Among 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Trent is the Tata Group retailer behind Westside, Zudio and Star. At Rs 3,165, the stock has a market capitalisation of Rs 1,52,824 crore and trades at 84.22 times earnings, while the industry P\/E is 60.81.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 20,189 crore, up 16.3% year on year, with net profit at Rs 1,721 crore, up 12.2%. The September 2026 quarter added revenue of Rs 5,899 crore (up 21.8%) and net profit of Rs 468 crore (up 25.4%).<\/p>\n<p>Return on equity is 24.62%, debt-to-equity is 0.37, and the dividend yield is 0.09%. Promoters hold 37.01%, foreign institutions 15.28% and domestic institutions 23.33% as of September 2026. Domestic institutional holding has risen from 19.98% to 23.33% over the last year. A point to keep in view: at a P\/E of 84.22, expectations are already high.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track these 26 percent quarterly profit growth stocks live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\"><\/span><strong>Growth Snapshot: Latest Full Year and Latest Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares year-on-year growth in revenue and net profit for all five 26 percent quarterly profit growth stocks, using filed results.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Full-Year Revenue Growth<\/th>\n<th>Full-Year Profit Growth<\/th>\n<th>Latest Quarter<\/th>\n<th>Quarter Revenue Growth<\/th>\n<th>Quarter Profit Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Dr Lal PathLabs<\/td>\n<td>12.1%<\/td>\n<td>3.6%<\/td>\n<td>Jun 2026<\/td>\n<td>18.9%<\/td>\n<td>27.2%<\/td>\n<\/tr>\n<tr>\n<td>Larsen and Toubro<\/td>\n<td>12.2%<\/td>\n<td>8.3%<\/td>\n<td>Sep 2026<\/td>\n<td>16.8%<\/td>\n<td>26.2%<\/td>\n<\/tr>\n<tr>\n<td>Marico<\/td>\n<td>25.1%<\/td>\n<td>9.3%<\/td>\n<td>Jun 2026<\/td>\n<td>22.2%<\/td>\n<td>27.1%<\/td>\n<\/tr>\n<tr>\n<td>Sun Pharmaceutical Industries<\/td>\n<td>12.7%<\/td>\n<td>5.3%<\/td>\n<td>Jun 2026<\/td>\n<td>11.9%<\/td>\n<td>26.4%<\/td>\n<\/tr>\n<tr>\n<td>Trent<\/td>\n<td>16.3%<\/td>\n<td>12.2%<\/td>\n<td>Sep 2026<\/td>\n<td>21.8%<\/td>\n<td>25.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Factors_That_Move_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Factors That Move 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four factors tend to drive 26 percent quarterly profit growth stocks, and each one is worth checking before a purchase.<\/p>\n<ul>\n<li><strong>Quarterly growth:<\/strong> Profit rose about 25% to 27% year on year.<\/li>\n<li><strong>Dividends:<\/strong> Dr Lal PathLabs yields about 1.1%.<\/li>\n<li><strong>Return on equity:<\/strong> Marico leads at about 42%.<\/li>\n<li><strong>Valuation:<\/strong> P\/E runs from about 25 to 84.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Keep_in_Mind_Before_Buying_26_Percent_Quarterly_Profit_Growth_Stocks\"><\/span><strong>Risks to Keep in Mind Before Buying 26 Percent Quarterly Profit Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The first risk is that Trent trades at a P\/E near 84, Dr Lal PathLabs near 59 and Marico near 51, while Larsen and Toubro trades near 25, so expectations differ widely. The second is that Larsen and Toubro carries the highest borrowings of the five and engineering earnings follow order inflows. Check results every quarter.<\/p>\n<p>On the numbers, Trent trades at the highest P\/E on this list at 84.22, so its earnings need to keep growing to support the price. 26 Percent Quarterly Profit Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>How to Choose 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Compare growth:<\/strong> Trent grew FY26 profit most, by about 12%.<\/li>\n<li><strong>Check P\/E:<\/strong> Larsen and Toubro trades lowest.<\/li>\n<li><strong>Read the yield:<\/strong> Dr Lal PathLabs pays the most.<\/li>\n<li><strong>Spread sectors:<\/strong> Mix diagnostics, engineering, consumer goods, pharma and retail.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_26_Percent_Quarterly_Profit_Growth_Stocks\"><\/span><strong>How to Invest in 26 Percent Quarterly Profit Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Shortlist two or three companies from this list that match your risk appetite.<\/li>\n<li>Open the Univest Screener and compare P\/E, ROE and debt for each stock.<\/li>\n<li>Check the latest quarterly results and shareholding pattern on NSE or BSE.<\/li>\n<li>Decide an amount you can hold for three to five years and split it into two or three purchases.<\/li>\n<li>Review the holding after every quarterly result instead of reacting to daily price moves.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Larsen and Toubro offers the lowest P\/E on this list at 25.06, Marico has the highest return on equity at 41.85%, and Trent posted the fastest net profit growth in its latest full year at 12.2%. Among the best 26 percent quarterly profit growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 26 percent quarterly profit growth stocks to buy.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_26_Percent_Quarterly_Profit_Growth_Stocks_to_Buy\"><\/span><strong>Frequently Asked Questions on 26 Percent Quarterly Profit Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_26_percent_quarterly_profit_growth_stocks_to_buy_in_November_2026\"><\/span><strong>Which are the best 26 percent quarterly profit growth stocks to buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The five 26 percent quarterly profit growth stocks on the November 2026 watchlist are Dr Lal PathLabs, Larsen and Toubro, Marico, Sun Pharmaceutical Industries and Trent. Larsen and Toubro has the lowest P\/E at 25.06, Marico has the highest ROE at 41.85%, and Trent grew net profit 12.2% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Larsen_and_Toubro_a_good_stock_to_buy_from_this_26_Percent_Quarterly_Profit_Growth_list\"><\/span><strong>Is Larsen and Toubro a good stock to buy from this 26 Percent Quarterly Profit Growth list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Larsen and Toubro is the largest company on this list with a market capitalisation of Rs 5,23,536 crore and a P\/E of 25.06 against an industry P\/E of 21.53. Its FY26 revenue rose 12.2% and net profit rose 8.3%, with return on equity at 15.81%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_these_26_percent_quarterly_profit_growth_stocks_expensive_right_now\"><\/span><strong>Are these 26 percent quarterly profit growth stocks expensive right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Valuations vary across the group. Dr Lal PathLabs trades at a P\/E of 58.78, Larsen and Toubro trades at a P\/E of 25.06, Marico trades at a P\/E of 51.46, Sun Pharmaceutical Industries trades at a P\/E of 34.91, Trent trades at a P\/E of 84.22, against industry multiples ranging from 21.53 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_26_percent_quarterly_profit_growth_stocks_pay_a_dividend\"><\/span><strong>Which of these 26 percent quarterly profit growth stocks pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend yields on this list are Dr Lal PathLabs 1.07%, Larsen and Toubro 1.00%, Marico 0.52%, Sun Pharmaceutical Industries 0.91%, Trent 0.09%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_stock_on_this_list_has_the_highest_return_on_equity\"><\/span><strong>Which stock on this list has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marico has the highest ROE on this list at 41.85%, followed by Trent at 24.62% and Dr Lal PathLabs at 20.13%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_26_percent_quarterly_profit_growth_stocks\"><\/span><strong>What are the risks of investing in 26 percent quarterly profit growth stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are very high valuations at three names, order inflow swings at the engineering major and a wide spread in sectors. On this list, Trent trades at the highest P\/E of 84.22, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_26_percent_quarterly_profit_growth_stocks_in_India\"><\/span><strong>How can I invest in 26 percent quarterly profit growth stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best 26 percent quarterly profit growth stocks to buy in November 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The five 26 percent quarterly profit growth stocks on the November 2026 watchlist are Dr Lal PathLabs, Larsen and Toubro, Marico, Sun Pharmaceutical Industries and Trent. Larsen and Toubro has the lowest P\/E at 25.06, Marico has the highest ROE at 41.85%, and Trent grew net profit 12.2% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.\"}},{\"@type\":\"Question\",\"name\":\"Is Larsen and Toubro a good stock to buy from this 26 Percent Quarterly Profit Growth list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Larsen and Toubro is the largest company on this list with a market capitalisation of Rs 5,23,536 crore and a P\/E of 25.06 against an industry P\/E of 21.53. Its FY26 revenue rose 12.2% and net profit rose 8.3%, with return on equity at 15.81%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"Are these 26 percent quarterly profit growth stocks expensive right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Valuations vary across the group. Dr Lal PathLabs trades at a P\/E of 58.78, Larsen and Toubro trades at a P\/E of 25.06, Marico trades at a P\/E of 51.46, Sun Pharmaceutical Industries trades at a P\/E of 34.91, Trent trades at a P\/E of 84.22, against industry multiples ranging from 21.53 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.\"}},{\"@type\":\"Question\",\"name\":\"Which of these 26 percent quarterly profit growth stocks pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividend yields on this list are Dr Lal PathLabs 1.07%, Larsen and Toubro 1.00%, Marico 0.52%, Sun Pharmaceutical Industries 0.91%, Trent 0.09%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.\"}},{\"@type\":\"Question\",\"name\":\"Which stock on this list has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Marico has the highest ROE on this list at 41.85%, followed by Trent at 24.62% and Dr Lal PathLabs at 20.13%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in 26 percent quarterly profit growth stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are very high valuations at three names, order inflow swings at the engineering major and a wide spread in sectors. On this list, Trent trades at the highest P\/E of 84.22, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in 26 percent quarterly profit growth stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Five 26 percent quarterly profit growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Dr Lal, L&#038;T, Marico, Sun Pharma and Trent.<\/p>\n","protected":false},"author":28,"featured_media":348706,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[24341,19434,7483,21197,8528],"class_list":["post-348707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-26-percent-quarterly-profit-growth-stocks","tag-larsen-and-toubro","tag-marico","tag-profit-growth-stocks","tag-trent"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348706"],"rank_math_title":["26 Percent Quarterly Profit Growth Stocks to Buy in Nov 2026"],"rank_math_description":["26 Percent Quarterly Profit Growth stocks to buy in November 2026: Dr Lal, L&amp;T, Marico, Sun Pharma and Trent, with FY26 growth, valuation, ROE and key risks for each."],"rank_math_focus_keyword":["26 percent quarterly profit growth stocks to buy"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/26-percent-quarterly-profit-growth-stocks-to-buy-in-november-2026-5-names-on-the.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=348707"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348707\/revisions"}],"predecessor-version":[{"id":348708,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348707\/revisions\/348708"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348706"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=348707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=348707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=348707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}